发明名称 |
Compositions and methods for eye whitening |
摘要 |
The invention provides compositions and methods for whitening of eyes. The provided compositions and methods utilize low concentrations of selective α-2 adrenergic receptor agonists. The compositions preferably include brimonidine. |
申请公布号 |
US9259425(B2) |
申请公布日期 |
2016.02.16 |
申请号 |
US201314044929 |
申请日期 |
2013.10.03 |
申请人 |
Eye Therapies LLC |
发明人 |
Horn Gerald |
分类号 |
A61K31/498;A61K9/00;A61K9/08;A61K45/06;A61K31/165;A61K31/198;A61K31/4168;A61K31/4174;A61K31/4178 |
主分类号 |
A61K31/498 |
代理机构 |
Wood, Phillips, Katz, Clark & Mortimer |
代理人 |
Wood, Phillips, Katz, Clark & Mortimer |
主权项 |
1. A method of increasing whiteness of an eye comprising administering to a subject in need thereof a composition comprising from between about 0.001% to about 0.05% weight by volume of a selective α-2 adrenergic receptor agonist selected from lofexidine, apraclonidine, mivazerol, clonidine, brimonidine, alpha methyl dopa, guanfacine, dexmedetomidine, (+)-(S)-4-[1-(2,3-dimethyl-phenyl)-ethyl]-1,3-dihydro-imidazole-2-thione, and 1-[(imidazolidin-2-yl)imino]indazole, or a pharmaceutically acceptable salt thereof. |
地址 |
Dana Point CA US |